Skip to main content

Table 3 Comparison of eGFR decline from baseline in the two groups at different time points

From: The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy

Follow-up time (months)

Supportive care group (n = 71)

Supportive care plus fluticasone group (n = 71)

p

3

1.5 [-4.4, 11.4]

-1.5[-12.3, 3.4]

0.1

6

2.5 [-7.0, 9.4]

-3.2 [-11.6, 10.9]

0.3

9

0.0 [-12.6, 19.3]

4.5 [-12.3, 23.1]

0.9